CoChat
Sign Up
Cited by 76

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Quantitative proteomic analysis of hepatocyte-secreted extracellular vesicles reveals candidate markers for liver toxicity

Rodríguez-Suárez, Eva, Gonzalez, Esperanza, Hughes, Chris, Conde-Vancells, Javier, Rudella, Andrea, Royo, Felix, Palomo, Laura, Elortza, Felix, Lu, Shelly C., Mato, Jose M., Vissers, Johannes P.C., Falcón-Pérez, Juan M.·2014·Journal of Proteomics
DOI 10.1016/j.jprot.2014.04.008PMC PMC5119459
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jprot.2014.04.008

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 3 references

Research works printed but not linked: 78

  1. Pierce, 2008, Eight-channel iTRAQ enables comparison of the activity of six leukemogenic tyrosine kinases, Mol Cell Proteomics, 7, 853, 10.1074/mcp.M700251-MCP200 · DOI
  2. Amanchy, 2005, Stable isotope labeling with amino acids in cell culture (SILAC) for studying dynamics of protein abundance and posttranslational modifications, Sci STKE, 267, l2
  3. Bonzon-Kulichenko, 2011, A robust method for quantitative high-throughput analysis of proteomes by 18O labeling, Mol Cell Proteomics, 10, 10.1074/mcp.M110.003335 · DOI
  4. Prokhorova, 2009, Stable isotope labeling by amino acids in cell culture (SILAC) and quantitative comparison of the membrane proteomes of self-renewing and differentiating human embryonic stem cells, Mol Cell Proteomics, 8, 959, 10.1074/mcp.M800287-MCP200 · DOI
  5. Lundberg, 2010, Defining the transcriptome and proteome in three functionally different human cell lines, Mol Syst Biol, 6, 450, 10.1038/msb.2010.106 · DOI · Paper page
  6. Liu, 2012, Integrative proteomics and tissue microarray profiling indicate the association between overexpressed serum proteins and non-small cell lung cancer, PLoS One, 7, e51748, 10.1371/journal.pone.0051748 · DOI
  7. Jahn, 2011, Peptide fingerprinting of Alzheimer's disease in cerebrospinal fluid: identification and prospective evaluation of new synaptic biomarkers, PLoS One, 6, e26540, 10.1371/journal.pone.0026540 · DOI
  8. Washburn, 2001, Large-scale analysis of the yeast proteome by multidimensional protein identification technology, Nat Biotechnol, 19, 242, 10.1038/85686 · DOI
  9. Li, 2005, A software suite for the generation and comparison of peptide arrays from sets of data collected by liquid chromatography−mass spectrometry, Mol Cell Proteomics, 4, 1328, 10.1074/mcp.M500141-MCP200 · DOI
  10. Wang, 2003, Quantification of proteins and metabolites by mass spectrometry without isotopic labeling or spiked standards, Anal Chem, 75, 4818, 10.1021/ac026468x · DOI
  11. Silva, 2006, Simultaneous qualitative and quantitative analysis of the Escherichia coli proteome, Mol Cell Proteomics, 5, 589, 10.1074/mcp.M500321-MCP200 · DOI
  12. Silva, 2005, Quantitative proteomic analysis by accurate mass retention time pairs, Anal Chem, 77, 2187, 10.1021/ac048455k · DOI
  13. Radulovic, 2004, Informatics platform for global proteomic profiling and biomarker discovery using liquid chromatography−tandem mass spectrometry, Mol Cell Proteomics, 3, 984, 10.1074/mcp.M400061-MCP200 · DOI
  14. Rodríguez-Suárez, 2013, The application of quantification techniques in proteomics for biomedical research, Mass Spectrom Rev, 32, 1, 10.1002/mas.21347 · DOI
  15. Simons, 2009, Exosomes—vesicular carriers for intercellular communication, Curr Opin Cell Biol, 21, 575, 10.1016/j.ceb.2009.03.007 · DOI
  16. Fevrier, 2004, Exosomes: endosomal-derived vesicles shipping extracellular messages, Curr Opin Cell Biol, 16, 415, 10.1016/j.ceb.2004.06.003 · DOI · Paper page
  17. Simons, 2009, Exosomes — vesicular carriers for intercellular communication, Curr Opin Cell Biol, 21, 575, 10.1016/j.ceb.2009.03.007 · DOI
  18. Gasser, 2003, Characterisation and properties of ectosomes released by human polymorphonuclear neutrophils, Exp Cell Res, 285, 243, 10.1016/S0014-4827(03)00055-7 · DOI
  19. Jimenez, 2003, Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis, Thromb Res, 109, 175, 10.1016/S0049-3848(03)00064-1 · DOI
  20. Almqvist, 2008, Serum-derived exosomes from antigen-fed mice prevent allergic sensitization in a model of allergic asthma, Immunology, 125, 21, 10.1111/j.1365-2567.2008.02812.x · DOI
  21. Al-Nedawi, 2008, Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells, Nat Cell Biol, 10, 619, 10.1038/ncb1725 · DOI
  22. Caby, 2005, Exosomal-like vesicles are present in human blood plasma, Int Immunol, 17, 879, 10.1093/intimm/dxh267 · DOI
  23. Piccin, 2007, Circulating microparticles: pathophysiology and clinical implications, Blood Rev, 21, 157, 10.1016/j.blre.2006.09.001 · DOI
  24. Shet, 2008, Characterizing blood microparticles: technical aspects and challenges, Vasc Health Risk Manag, 4, 769, 10.2147/VHRM.S955 · DOI
  25. Wubbolts, 2003, Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation, J Biol Chem, 278, 10963, 10.1074/jbc.M207550200 · DOI
  26. Cocucci, 2009, Shedding microvesicles: artefacts no more, Trends Cell Biol, 19, 43, 10.1016/j.tcb.2008.11.003 · DOI · Paper page
  27. Simpson, 2009, Exosomes: proteomic insights and diagnostic potential, Expert Rev Proteomics, 6, 267, 10.1586/epr.09.17 · DOI
  28. Pap, 2009, Highlights of a new type of intercellular communication: microvesicle-based information transfer, Inflamm Res, 58, 1, 10.1007/s00011-008-8210-7 · DOI
  29. Wieckowski, 2006, Human tumor-derived vs dendritic cell-derived exosomes have distinct biologic roles and molecular profiles, Immunol Res, 36, 247, 10.1385/IR:36:1:247 · DOI
  30. Conde-Vancells, 2008, Characterization and comprehensive proteome profiling of exosomes secreted by hepatocytes, J Proteome Res, 7, 5157, 10.1021/pr8004887 · DOI
  31. Keppler, 1968, Experimental hepatitis induced by d-galactosamine, Exp Mol Pathol, 9, 279, 10.1016/0014-4800(68)90042-7 · DOI
  32. Han, 2002, Intestinal endotoxemia as a pathogenetic mechanism in liver failure, World J Gastroenterol, 8, 961, 10.3748/wjg.v8.i6.961 · DOI
  33. Kaido, 1997, Continuous hepatocyte growth factor supply prevents lipopolysaccharide-induced liver injury in rats, FEBS Lett, 411, 378, 10.1016/S0014-5793(97)00744-8 · DOI · Paper page
  34. Li, 2012, Yohimbine enhances protection of berberine against LPS-induced mouse lethality through multiple mechanisms, PLoS One, 7, e52863, 10.1371/journal.pone.0052863 · DOI
  35. Morrison, 1987, Endotoxins and disease mechanisms, Annu Rev Med, 38, 417, 10.1146/annurev.me.38.020187.002221 · DOI
  36. Ponzetti, 2010, Cyclic AMP-guanine exchange factor activation inhibits JNK-dependent lipopolysaccharide-induced apoptosis in rat hepatocytes, Hepat Med, 2010, 1
  37. Polsky-Fisher, 2006, Effect of cytochromes P450 chemical inhibitors and monoclonal antibodies on human liver microsomal esterase activity, Drug Metab Dispos, 34, 1361, 10.1124/dmd.106.009704 · DOI
  38. Seglen, 1976, Preparation of isolated rat liver cells, Methods Cell Biol, 13, 29, 10.1016/S0091-679X(08)61797-5 · DOI
  39. Gilar, 2005, Two-dimensional separation of peptides using RP-RP-HPLC system with different pH in first and second separation dimensions, J Sep Sci, 28, 1694, 10.1002/jssc.200500116 · DOI
  40. Silva, 2006, Absolute quantification of proteins by LCMSE: a virtue of parallel MS acquisition, Mol Cell Proteomics, 5, 144, 10.1074/mcp.M500230-MCP200 · DOI · Paper page
  41. Li, 2009, Database searching and accounting of multiplexed precursor and product ion spectra from the data independent analysis of simple and complex peptide mixtures, Proteomics, 9, 1696, 10.1002/pmic.200800564 · DOI
  42. Yu, 2011, Systematic proteomic analysis of human hepotacellular carcinoma cells reveals molecular pathways and networks involved in metastasis, Mol Biosyst, 7, 1908, 10.1039/c0mb00265h · DOI
  43. Pitarch, 2011, Prediction of the clinical outcome in invasive Candidiasis patients based on molecular fingerprints of five anti-Candida antibodies in serum, Mol Cell Proteomics, 10, 10.1074/mcp.M110.004010 · DOI
  44. Levin, 2011, The role of statistical power analysis in quantitative proteomics, Proteomics, 11, 2565, 10.1002/pmic.201100033 · DOI
  45. Banerjee, 2008, Identification of proteins to predict the molecular basis for the observed gender susceptibility in a rat model of alcoholic steatohepatitis by 2-D gel proteomics, Proteomics, 8, 4327, 10.1002/pmic.200700368 · DOI
  46. Lorenz, 2009, Proteomics reveals acute pro-inflammatory and protective responses in rat Kupffer cells and hepatocytes after chemical initiation of liver cancer and after LPS and IL-6, Proteomics Clin Appl, 3, 947, 10.1002/prca.200800173 · DOI
  47. Lu, 2012, Triptolide attenuate the oxidative stress induced by LPS/D-GalN in mice, J Cell Biochem, 113, 1022, 10.1002/jcb.23434 · DOI
  48. Lv, 2008, Senescence marker protein 30 in acute liver failure: validation of a mass spectrometry proteomics assay, BMC Gastroenterol, 8, 17, 10.1186/1471-230X-8-17 · DOI
  49. Rodriguez-Ariza, 2005, Altered protein expression and protein nitration pattern during d-galactosamine-induced cell death in human hepatocytes: a proteomic analysis, Liver Int, 25, 1259, 10.1111/j.1478-3231.2005.01172.x · DOI
  50. Sun, 2003, Evaluation of oxidative stress during apoptosis and necrosis caused by d-galactosamine in rat liver, Biochem Pharmacol, 65, 101, 10.1016/S0006-2952(02)01420-X · DOI
  51. Ramaiah, 2011, Preclinical safety assessment: current gaps, challenges, and approaches in identifying translatable biomarkers of drug-induced liver injury, Clin Lab Med, 31, 161, 10.1016/j.cll.2010.10.004 · DOI
  52. Ganz, 2011, Lipopolysaccharide induces and activates the Nalp3 inflammasome in the liver, World J Gastroenterol, 17, 4772, 10.3748/wjg.v17.i43.4772 · DOI
  53. Burdette, 2011, Hepatitis C virus activates interleukin-1beta via caspase-1-inflammasome complex, J Gen Virol, 93, 235, 10.1099/vir.0.034033-0 · DOI
  54. Csak, 2011, Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells, Hepatology, 54, 133, 10.1002/hep.24341 · DOI · Paper page
  55. Scott, 2008, Beta2-integrin-induced p38 MAPK activation is a key mediator in the CD14/TLR4/MD2-dependent uptake of lipopolysaccharide by hepatocytes, J Biol Chem, 283, 29433, 10.1074/jbc.M803905200 · DOI
  56. Liu, 2002, Role of toll-like receptors in changes in gene expression and NF-kappa B activation in mouse hepatocytes stimulated with lipopolysaccharide, Infect Immun, 70, 3433, 10.1128/IAI.70.7.3433-3442.2002 · DOI · Paper page
  57. Ishiguro, 2001, Syndecan-4 deficiency leads to high mortality of lipopolysaccharide-injected mice, J Biol Chem, 276, 47483, 10.1074/jbc.M106268200 · DOI
  58. Reis, 2011, LPS-induced formation of immunoproteasomes: TNF-alpha and nitric oxide production are regulated by altered composition of proteasome-active sites, Cell Biochem Biophys, 60, 77, 10.1007/s12013-011-9182-8 · DOI
  59. Stohwasser, 2000, Biochemical analysis of proteasomes from mouse microglia: induction of immunoproteasomes by interferon-gamma and lipopolysaccharide, Glia, 29, 355, 10.1002/(SICI)1098-1136(20000215)29:4<355::AID-GLIA6>3.0.CO;2-4 · DOI
  60. Angeles, 2012, Immune and non-immune functions of the immunoproteasome, Front Biosci, 17, 1904, 10.2741/4027 · DOI
  61. Coen, 2007, The mechanism of galactosamine toxicity revisited; a metabonomic study, J Proteome Res, 6, 2711, 10.1021/pr070164f · DOI
  62. Chen, 2004, Impaired liver regeneration in mice lacking methionine adenosyltransferase 1A, FASEB J, 18, 914, 10.1096/fj.03-1204fje · DOI
  63. Brodsky, 2008, Dynamics of circulating microparticles in liver transplant patients, J Gastrointestin Liver Dis, 17, 261
  64. Butler, 2008, The antigen for Hep Par 1 antibody is the urea cycle enzyme carbamoyl phosphate synthetase 1, Lab Invest, 88, 78, 10.1038/labinvest.3700699 · DOI
  65. Potter, 2006, Carboxylesterases — detoxifying enzymes and targets for drug therapy, Curr Med Chem, 13, 1045, 10.2174/092986706776360969 · DOI
  66. Satoh, 1998, The mammalian carboxylesterases: from molecules to functions, Annu Rev Pharmacol Toxicol, 38, 257, 10.1146/annurev.pharmtox.38.1.257 · DOI
  67. Redinbo, 2005, Mammalian carboxylesterases: from drug targets to protein therapeutics, Drug Discov Today, 10, 313, 10.1016/S1359-6446(05)03383-0 · DOI
  68. Hatfield, 2011, Carboxylesterase inhibitors, Expert Opin Ther Pat, 21, 1159, 10.1517/13543776.2011.586339 · DOI
  69. Hatfield, 2010, Biochemical and molecular analysis of carboxylesterase-mediated hydrolysis of cocaine and heroin, Br J Pharmacol, 160, 1916, 10.1111/j.1476-5381.2010.00700.x · DOI
  70. Pindel, 1997, Purification and cloning of a broad substrate specificity human liver carboxylesterase that catalyzes the hydrolysis of cocaine and heroin, J Biol Chem, 272, 14769, 10.1074/jbc.272.23.14769 · DOI
  71. Humerickhouse, 2000, Characterization of CPT-11 hydrolysis by human liver carboxylesterase isoforms hCE-1 and hCE-2, Cancer Res, 60, 1189
  72. Quinney, 2005, Hydrolysis of capecitabine to 5′-deoxy-5-fluorocytidine by human carboxylesterases and inhibition by loperamide, J Pharmacol Exp Ther, 313, 1011, 10.1124/jpet.104.081265 · DOI
  73. Crow, 2007, Hydrolysis of pyrethroids by human and rat tissues: examination of intestinal, liver and serum carboxylesterases, Toxicol Appl Pharmacol, 221, 1, 10.1016/j.taap.2007.03.002 · DOI
  74. Shi, 2006, Anti-influenza prodrug oseltamivir is activated by carboxylesterase human carboxylesterase 1, and the activation is inhibited by antiplatelet agent clopidogrel, J Pharmacol Exp Ther, 319, 1477, 10.1124/jpet.106.111807 · DOI
  75. Sun, 2004, Methylphenidate is stereoselectively hydrolyzed by human carboxylesterase CES1A1, J Pharmacol Exp Ther, 310, 469, 10.1124/jpet.104.067116 · DOI
  76. Tang, 2006, Antiplatelet agents aspirin and clopidogrel are hydrolyzed by distinct carboxylesterases, and clopidogrel is transesterificated in the presence of ethyl alcohol, J Pharmacol Exp Ther, 319, 1467, 10.1124/jpet.106.110577 · DOI
  77. Zhang, 1999, Binding and hydrolysis of meperidine by human liver carboxylesterase hCE-1, J Pharmacol Exp Ther, 290, 314, 10.1016/S0022-3565(24)34901-8 · DOI
  78. Huang, 1993, Effect of hepatotoxic doses of paracetamol and carbon tetrachloride on the serum and hepatic carboxylesterase activity in mice, J Pharm Pharmacol, 45, 458, 10.1111/j.2042-7158.1993.tb05576.x · DOI

Cited by

Sorted by citations

See all 76

Metadata

Authors
Rodríguez-Suárez, E., Gonzalez, E., Hughes, C., Conde-Vancells, J., Rudella, A., Royo, F., Palomo, L., Elortza, F., Lu, S. C., Mato, J. M., Vissers, J. P. C., & Falcón-Pérez, J. M.
Venue
Journal of Proteomics
Publisher
Elsevier BV
Published
2014-05
Volume
103
Pages
227-240
ISSN
1874-3919
DOI
10.1016/j.jprot.2014.04.008
PMC
PMC5119459
Cited by
76
References
3
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Funders
  • Fondo de Investigaciones Sanitarias (Institute of Health Carlos III (06/0621, PS09/00526, PI12/01064)
  • Spanish Ministry (J.M.F.PRYC-2007-00228)
  • National Institute of Health (R01 AT004896)
  • Centro de Investigación Biomédica en Red en el Área temática de Enfermedades Hepáticas y Digestivas (CIBERehd)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review